0000950123-18-011333.txt : 20181113 0000950123-18-011333.hdr.sgml : 20181113 20181113160547 ACCESSION NUMBER: 0000950123-18-011333 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20180930 FILED AS OF DATE: 20181113 DATE AS OF CHANGE: 20181113 EFFECTIVENESS DATE: 20181113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VHCP Management III, LLC CENTRAL INDEX KEY: 0001738053 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-18930 FILM NUMBER: 181177932 BUSINESS ADDRESS: STREET 1: 7 BRYANT PARK STREET 2: 23RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: (650) 561-9580 MAIL ADDRESS: STREET 1: 7 BRYANT PARK STREET 2: 23RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 13F-HR 1 primary_doc.xml 13F-HR LIVE false true false 0001738053 XXXXXXXX 09-30-2018 09-30-2018 VHCP Management III, LLC

7 Bryant Park 23rd Floor New York NY 10018

13F HOLDINGS REPORT 028-18930 N David L. Stepp 650-561-9580 /s/ David L. Stepp Palo Alto CA 11-13-2018 0 13 132350 false INFORMATION TABLE 2 form13fInfoTable.xml INFORMATION TABLE FOR FORM 13F Apellis Pharmaceuticals Inc COM 03753U106 894 50290 SH SOLE 50290 0 0 Bellerophon Therapeutics COM 078771102 2456 2274370 SH SOLE 2274370 0 0 BioCryst Pharmaceuticals Inc COM 09058V103 23356 3061091 SH SOLE 3061091 0 0 ChemoCentryx Inc COM 16383L106 493 39036 SH SOLE 39036 0 0 Constellation Pharmaceuticals COM 210373106 449 66667 SH SOLE 66667 0 0 Endocyte Inc COM 29269A102 10656 600000 SH SOLE 600000 0 0 Gemphire Therapeutics COM 36870A108 1791 869538 SH SOLE 869538 0 0 Kadmon Holdings Inc. COM 48283N106 7978 2388572 SH SOLE 2388572 0 0 Kalvista Pharmaceuticals COM 483497103 28410 1284931 SH SOLE 1284931 0 0 Kiniksa Pharmaceuticals Ltd COM G5269C101 8358 327777 SH SOLE 327777 0 0 Marinus Pharmaceuticals Inc COM 56854Q101 6723 672271 SH SOLE 672271 0 0 Obseva SA COM H5861P103 20911 1159789 SH SOLE 1159789 0 0 Tricida Inc COM 89610F101 19875 650585 SH SOLE 650585 0 0